-
1 Comment
CellSeed Inc is currently in a long term downtrend where the price is trading 1.9% below its 200 day moving average.
From a valuation standpoint, the stock is 69.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 21.7.
CellSeed Inc's total revenue rose by 77.4% to $116M since the same quarter in the previous year.
Its net income has increased by 23.0% to $-173M since the same quarter in the previous year.
Based on the above factors, CellSeed Inc gets an overall score of 3/5.
ISIN | JP3423530009 |
---|---|
Exchange | TSE |
CurrencyCode | JPY |
Sector | Healthcare |
Industry | Biotechnology |
Beta | 0.94 |
---|---|
PE Ratio | None |
Target Price | None |
Market Cap | 21B |
Dividend Yield | None |
CellSeed Inc. develops cell sheet regenerative medicines. It is involved in the research, development, and commercialization of cell-sheet regenerative medicine products, such as epithelial cell sheet for esophageal regeneration, regenerated cartilage sheet, and chondrocyte sheet for the treatment of knee osteoarthritis. The company also offers UpCell, a temperature-responsive cell cultureware for cell-sheet engineering; RepCell, a temperature-responsive cell cutureware for cell collection; and HydroCell, a low cell binding cultureware. In addition, it provides peripheral equipment, including ThermoPlate III, a heating element made by a transparent glass plate; and cellZscope, an automated cell monitoring system, as well as contract development and manufacturing services. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7776.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025